title: Increased Mortality during Bleomycin-induced Pulmonary Fibrosis due to Low Endogenous Activated Protein C Levels.
authors.affiliation: 1 Academic Medical Center Amsterdam, the Netherlands.
authors.forename: Cong
authors.initials: C
authors.lastname: Lin
authors.affiliation: 2 Erasmus Medical Centre Rotterdam, the Netherlands.
authors.forename: Jan
authors.initials: J
authors.lastname: von der Thüsen
authors.affiliation: 1 Academic Medical Center Amsterdam, the Netherlands.
authors.forename: Tom
authors.initials: T
authors.lastname: van der Poll
authors.affiliation: 1 Academic Medical Center Amsterdam, the Netherlands.|3 Medical School Xavier Bichat Paris, France and.|4 LabEx Inflamex Paris, France.
authors.forename: Keren
authors.initials: K
authors.lastname: Borensztajn
authors.affiliation: 1 Academic Medical Center Amsterdam, the Netherlands.
authors.forename: C Arnold
authors.initials: CA
authors.lastname: Spek
mesh_terms: D001281:Atrial Fibrillation / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D054990:Idiopathic Pulmonary Fibrosis / Q000150:complications*; D008297:Male; D013924:Thrombophlebitis / Q000150:complications* / Q000188:drug therapy*; D014859:Warfarin / Q000009:adverse effects*
chemical_list: D014859:Warfarin